IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 375 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $31,725 | -0.8% | 665,674 | -9.7% | 0.01% | -9.1% |
Q1 2024 | $31,966 | -16.3% | 737,387 | -2.3% | 0.01% | -21.4% |
Q4 2023 | $38,170 | +20.3% | 754,508 | +7.9% | 0.01% | -30.0% |
Q3 2023 | $31,733 | +42.6% | 699,553 | +29.0% | 0.02% | +42.9% |
Q2 2023 | $22,247 | +35.7% | 542,232 | +18.2% | 0.01% | +75.0% |
Q1 2023 | $16,397 | -14.4% | 458,817 | -9.6% | 0.01% | -11.1% |
Q4 2022 | $19,162 | -99.9% | 507,311 | +0.6% | 0.01% | -62.5% |
Q3 2022 | $22,313,000 | +70.0% | 504,488 | +42.3% | 0.02% | +200.0% |
Q2 2022 | $13,127,000 | +12.0% | 354,579 | +12.1% | 0.01% | -11.1% |
Q1 2022 | $11,717,000 | -41.6% | 316,350 | -52.1% | 0.01% | +125.0% |
Q4 2021 | $20,078,000 | +81.2% | 659,876 | +99.8% | 0.00% | -20.0% |
Q3 2021 | $11,079,000 | -23.7% | 330,291 | -9.3% | 0.01% | -28.6% |
Q2 2021 | $14,520,000 | +226.9% | 363,996 | +268.5% | 0.01% | +250.0% |
Q1 2021 | $4,442,000 | -33.6% | 98,771 | -16.5% | 0.00% | -33.3% |
Q4 2020 | $6,687,000 | +13.2% | 118,265 | -5.0% | 0.00% | 0.0% |
Q3 2020 | $5,905,000 | -25.3% | 124,447 | -7.1% | 0.00% | -50.0% |
Q2 2020 | $7,900,000 | +17.2% | 134,001 | -6.0% | 0.01% | +20.0% |
Q1 2020 | $6,743,000 | -60.6% | 142,622 | -49.6% | 0.01% | -44.4% |
Q4 2019 | $17,107,000 | +32.8% | 283,180 | +31.7% | 0.01% | +12.5% |
Q3 2019 | $12,884,000 | -41.8% | 215,059 | -37.6% | 0.01% | -38.5% |
Q2 2019 | $22,142,000 | +4.7% | 344,493 | +32.2% | 0.01% | -13.3% |
Q1 2019 | $21,145,000 | +38.4% | 260,508 | -7.8% | 0.02% | +15.4% |
Q4 2018 | $15,279,000 | -17.2% | 282,657 | -21.0% | 0.01% | 0.0% |
Q3 2018 | $18,452,000 | +91.5% | 357,736 | +54.8% | 0.01% | +85.7% |
Q2 2018 | $9,633,000 | -30.9% | 231,155 | -26.9% | 0.01% | -36.4% |
Q1 2018 | $13,942,000 | -23.3% | 316,345 | -12.4% | 0.01% | -31.2% |
Q4 2017 | $18,166,000 | +0.2% | 361,168 | +1.0% | 0.02% | -15.8% |
Q3 2017 | $18,126,000 | +31.8% | 357,507 | +32.3% | 0.02% | +26.7% |
Q2 2017 | $13,748,000 | -8.4% | 270,251 | -27.6% | 0.02% | -6.2% |
Q1 2017 | $15,008,000 | +25.7% | 373,290 | +49.5% | 0.02% | +33.3% |
Q4 2016 | $11,944,000 | -8.8% | 249,728 | -30.1% | 0.01% | -14.3% |
Q3 2016 | $13,092,000 | +152.6% | 357,351 | +60.6% | 0.01% | +133.3% |
Q2 2016 | $5,182,000 | -21.0% | 222,466 | +35.7% | 0.01% | -40.0% |
Q1 2016 | $6,557,000 | -42.8% | 163,936 | -12.7% | 0.01% | -28.6% |
Q4 2015 | $11,457,000 | – | 187,795 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sicart Associates LLC | 367,360 | $14,768,000 | 10.67% |
BB BIOTECH AG | 7,461,295 | $299,944,000 | 9.81% |
TANAKA CAPITAL MANAGEMENT INC | 83,399 | $3,353,000 | 7.39% |
DOWLING & YAHNKE LLC | 675,843 | $27,169,000 | 2.89% |
Opus Point Partners Management, LLC | 78,900 | $3,172,000 | 2.35% |
Motley Fool Asset Management LLC | 259,000 | $10,412,000 | 2.25% |
ARK Investment Management | 127,563 | $5,128,000 | 1.48% |
Motley Fool Wealth Management, LLC | 325,965 | $13,104,000 | 1.26% |
PINNACLE ASSOCIATES LTD | 1,514,710 | $60,891,000 | 1.16% |
Bellevue Group AG | 205,253 | $8,251,000 | 1.10% |